CBD Dosing Chart: How Much Should You Take
March 30th, 2018
With 29 States and Washington D.C. sporting medical cannabis programs, it’s a safe assumption to say that cannabis as medicine is effectively accepted by the majority of the U.S., by State. Medical cannabis is an extremely broad-scoped science, but two compounds are referenced the most: THC and CBD. While THC is the active compound in cannabis that causes euphoria and the feeling of being “high”, CBD is a non-psychoactive compound also found in cannabis that has impressive medical properties.
CBD is used for pain relief, as an anti-inflammatory, an anticonvulsant, and as an antioxidant, among other things.
CBD typically comes in the forms such as:
- CBD Oil (for ingestion)
- CBD concentrates (for vaporization)
- CBD edibles (for ingestion)
But, it also can be found infused into topical ointments for skin conditions and muscle aches, as well as in a variety of products ranging from soda to rolling papers. Given the breadth of ways to deliver for CBD to the system, dosing information is critical for ideal CBD intake as well as maximizing utilization of the medication supply, IE: reducing waste.
What’s the Right Dose?
How much CBD should you take? This question gets asked over and over, yet the answer is always the same – it is different for each person. There are several factors that need to be accounted for before thinking about how much CBD should take and how often.
Some of these factors include:
Also, it is important to note that some hemp-derived CBD products are considered dietary supplements, and are readily distributed online and in medical legal states – dosing charts are always based on the use of high quality CBD oil, extracted from cannabis plants that are bred for the genetic quality of being high in CBD.
|≥25 pounds||26-45 pounds||46-85 pounds||86-150 pounds||151-240 pounds||>241 pounds|
|Mild||4.5 mg||6 mg||9 mg||12 mg||18 mg||22.5 mg|
|Medium||6 mg||9 mg||15 mg||15 mg||22.5 mg||30 mg|
|Severe||9 mg||12 mg||18 mg||18 mg||27 mg||45 mg|
This chart provides dosing instruction in milligrams, based on the weight of the patient. As mentioned, weight is only one of several important considerations when determining dose. Your actual dose should account for your condition, severity, and metabolism most of all beyond your weight. CBD actually has different effects at higher doses, (biphasic) so if you’re not achieving the desired result at first, know that starting small and then increasing your dose steadily, as needed, until you reach your desired effect is usually encouraged. In some cases of severe illness, shock therapy using extremely high doses of CBD and /or THC may be appropriate, so always follow the prescription of a doctor for your best results.
Calculating Drops: CBD
Different CBD products will have different strengths and potencies: luckily, figuring out how many drops yield how much CBD isn’t rocket science.
First, find the serving size for your CBD oil. This means finding how many drops contains how much CBD. Typically, product packaging will have this information.
Next, find the milligrams of CBD that the serving size contains.
Once you have that information, find your recommended dose according to weight. Make any necessary adjustments upward based on medical advice or associated considerations of dosing.
Lastly, do the math.
For example, if 10 drops of oil contains 100 mg of CBD, that means each drop contains 10 mg. For a 250 lb. individual with mild pain, the recommended dose is 30 mg.
A 250 lb. individual with mild pain would take three drops to achieve the correct dose.
Of course, it’s always a good idea to consult with a qualified physician before consuming CBD products.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.